Abstract
We report the presence of estrogen receptor (ER) in the ligamentum capitis femoris (LCF) and hip capsule. We took 15 LCF and hip capsule biopsies from 15 patients undergoing hip surgery for the Developmental Dysplasia of the hip (DDH) and 15 hip capsules and LCF’s from intrauterine ex fetuses. The mean age of the babies was 10.3 months (6–18 months) at the time of surgery. Total 60 specimens were grouped into two as the DDH group and the control group and each of these groups were further divided into two to generate the groups for the LCF and hip capsules. Full thickness 1 x 1 cm anterior capsule and LCF portions were taken as biopsy specimens.
An immunohistochemical study using monoclonal antibody against to estrogen receptors was performed to identify estrogen target cells in the hip capsule and LCF. The positive rates of ER staining in the control group were % 1.6 ± 0.2 for the LCF and % 1.3 ± 0.2 for the hip capsule, in the DDH group positive rates of ER staining were %2.5 ± 0.3 for the LCF and % 2.0 ± 0.3 for the hip capsule. The positive rates of ER staining in LCF and hip capsule of the control group were significantly lower than that in the DDH group in both groups we found ER’s to be significantly lower in the hip capsule than in LCF. The presence of estrogen receptors in the LCF and hip capsule supports the effect of estrogen in etiology of the DDH.
Correspondence should be addressed to: EFORT Central Office, Technoparkstrasse 1, CH – 8005 Zürich, Switzerland. Email: office@efort.org
